CREMON, CESARE
 Distribuzione geografica
Continente #
NA - Nord America 5.224
EU - Europa 2.760
AS - Asia 1.206
AF - Africa 161
SA - Sud America 14
OC - Oceania 12
Totale 9.377
Nazione #
US - Stati Uniti d'America 5.215
GB - Regno Unito 672
IT - Italia 577
CN - Cina 451
DE - Germania 419
SE - Svezia 309
SG - Singapore 291
VN - Vietnam 276
UA - Ucraina 174
IN - India 115
IE - Irlanda 108
FR - Francia 105
RU - Federazione Russa 95
CH - Svizzera 66
EE - Estonia 57
ZA - Sudafrica 55
TG - Togo 49
FI - Finlandia 47
BG - Bulgaria 35
NG - Nigeria 35
AT - Austria 32
JO - Giordania 29
BE - Belgio 20
IR - Iran 15
SC - Seychelles 12
NL - Olanda 10
AU - Australia 9
CA - Canada 9
CI - Costa d'Avorio 9
GR - Grecia 9
BR - Brasile 8
JP - Giappone 7
HK - Hong Kong 5
HR - Croazia 5
ES - Italia 4
PL - Polonia 4
RO - Romania 4
ID - Indonesia 3
LB - Libano 3
NZ - Nuova Zelanda 3
AR - Argentina 2
CL - Cile 2
EC - Ecuador 2
IL - Israele 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
TR - Turchia 2
BA - Bosnia-Erzegovina 1
HU - Ungheria 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MY - Malesia 1
SM - San Marino 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 9.377
Città #
Houston 1.731
Southend 601
Fairfield 466
Chandler 313
Ashburn 273
Singapore 263
Dong Ket 225
Woodbridge 220
Wilmington 189
Seattle 174
Cambridge 156
Ann Arbor 150
Santa Clara 148
Princeton 138
Dublin 108
Jacksonville 104
Nanjing 76
Boardman 75
Bologna 72
Padova 71
Munich 69
Westminster 62
Bern 60
Berlin 56
Lomé 49
New York 48
Helsinki 46
Frankfurt am Main 41
Jinan 37
Rome 35
Sofia 35
Bremen 34
Shenyang 34
Abeokuta 33
Milan 31
Saint Petersburg 30
Amman 29
Vienna 28
Florence 25
Beijing 24
San Diego 23
Turin 22
Dearborn 21
Tianjin 20
Brussels 19
Changsha 19
Mülheim 19
Hebei 18
Medford 16
Mountain View 15
Shanghai 15
Haikou 14
Nanchang 14
Norwalk 14
Guangzhou 12
Mahé 12
Hangzhou 11
Jiaxing 11
Washington 11
Falls Church 10
Los Angeles 10
Redwood City 10
Verona 10
Abidjan 9
Des Moines 9
Ningbo 9
Taizhou 9
Lanzhou 8
San Francisco 8
Zhengzhou 8
Kunming 7
Olalla 7
São Paulo 7
Taiyuan 7
Chengdu 6
Costa Mesa 6
Kuban 6
Toronto 6
Ferrara 5
Malga Leno 5
Petilia Policastro 5
Tokyo 5
Zanjan 5
Ardabil 4
Bari 4
Genoa 4
Hefei 4
Hyderabad 4
Moscow 4
Paris 4
Pescate 4
Phoenix 4
San Venanzo 4
Shenzhen 4
Silea 4
Siracusa 4
Andover 3
Bovolone 3
Bühl 3
Castellarano 3
Totale 6.906
Nome #
New pathophysiological mechanisms in irritable bowel syndrome. 1.756
La sindrome dell'intestino irritabile. 228
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. 195
Il sistema nervoso enterico. 193
Diagnosis and therapy of irritable bowel syndrome 186
Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome. 179
null 179
Randomised controlled trial of mesalazine in IBS 167
Almost all irritable bowel syndromes are post-infectious and respond to probiotics: controversial issues. 163
Salmonella gastroenteritis during childhood is a risk factor for irritable bowel syndrome in adulthood 157
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons 157
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome 152
Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. 152
Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis 151
New insights into human enteric neuropathies. 150
CLINICAL AND NEUROCHEMICAL FEATURES OF CHRONIC CONSTIPATION IN PATIENTS WITH PARKINSON DISEASE 150
MALATTIA DA REFLUSSO GASTROESOFAGEO 141
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome 141
Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome 139
Serine proteases: new players in diarrhoea-predominant irritable bowel syndrome 136
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. 136
Antiflagellin antibodies suggest infective participation in irritable bowel syndrome pathogenesis. 136
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. 135
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. 134
Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome 133
Diagnostic challenges of symptomatic uncomplicated diverticular disease 132
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism 129
Gut microbiota and related diseases: clinical features. 126
Post-infectious Irritable Bowel Syndrome. 123
Sigmoid compliance and visceral perception in spinal cord injury patients 123
The immune system in irritable bowel syndrome. 122
Gastroesophageal reflux disease: clinical and pathophysiological features (part I)] 118
Malattia da reflusso gastroesofageo. 117
Interactions between commensal bacteria and gut sensorimotor function in health and disease. 116
Gastroesophageal reflux disease: therapeutic features (Part II)] 115
Postinfectious irritable bowel syndrome. 112
Colonic mucosal mast cell mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons. 111
null 108
[Some practical questions on chronic stipsis treatment with prucalopride] 107
Patient-reported outcomes and gut dysmotility in functional gastrointestinal disorders. 106
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 105
Natural history of intestinal failure induced by chronic idiopathic intestinal pseudo-obstruction 105
Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS 104
Supernatants of irritable bowel syndrome mucosal biopsies impair human colonic smooth muscle contractility 104
Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. 100
Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use. 99
How relevant is symptom evaluation in NERD? 99
Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. 99
Enteric neuron involvement in dysmotilities and responses to inflammation. 98
Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. 98
La sindrome dell’intestino irritabile: novita’ sulla fisiopatologia. 95
Treatment of diverticular disease with aminosalicylates: The evidence 95
Neuro-immune interactions and anorectal motility in children with food-allergy related constipation. 94
Neuroimmune interaction and anorectal motility in children with food allergy-related chronic constipation. 93
Idiopathic achalasia is not allelic to alacrima achalasia adrenal insufficiency syndrome at the ALADIN locus 92
Norovirus gastroenteritis. 90
Reduced Bcl-2 expression and increased myenteric neuron apoptosis in patients with idiopathic enteric neuropathy (IEN) 90
Nerve Growth and Plasticity in the Colonic Mucosa of Patients With Irritable Bowel Syndrome 89
Mast cells are increased in the colonic mucosa of patients with irritable bowel syndrome and excite visceral sensory pathways. 82
null 77
Inflammatory bowel disease and irritable bowel syndrome: similarities and differences 74
What is the effect of inflammation on intestinal function? 74
The effect of colonic mucosal mediators from patients with irritable bowel syndrome on tritiated Ach release and motor responses in strips of human colon. 69
Allergic Proctocolitis Is a Risk Factor for Functional Gastrointestinal Disorders in Children 46
Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial 45
Totale 9.527
Categoria #
all - tutte 20.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.649


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.191 0 0 0 0 0 0 404 241 239 106 63 138
2020/20211.028 205 66 42 36 14 48 14 49 95 87 55 317
2021/20221.517 132 57 78 79 100 67 52 76 43 76 511 246
2022/20231.489 151 222 116 204 110 105 24 89 234 35 84 115
2023/2024481 39 64 46 45 54 128 28 12 6 19 18 22
2024/2025955 83 233 145 97 240 123 34 0 0 0 0 0
Totale 9.527